{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:21:04Z","timestamp":1777051264292,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FM Area Foundation"},{"name":"North Dakota Board of Pharmacy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.sapharm.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T08:28:52Z","timestamp":1531902532000},"page":"1032-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-1103","authenticated-orcid":false,"given":"Mark A.","family":"Strand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-5881","authenticated-orcid":false,"given":"Heidi","family":"Eukel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Burck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"43","key":"10.1016\/j.sapharm.2018.07.011_bib1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2013-United States, 1999\u20132008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2018.07.011_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses \u2014 United States, july 2016\u2013september 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2018.07.011_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2015.04.003","article-title":"Prescription opioid abuse: problems and responses","volume":"80","author":"Compton","year":"2015","journal-title":"Prev Med"},{"issue":"7","key":"10.1016\/j.sapharm.2018.07.011_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.011_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/02791072.2012.704591","article-title":"\u201cHooked on\u201d prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients","volume":"44","author":"Peavy","year":"2012","journal-title":"J Psychoact Drugs"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.011_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugpo.2012.01.012","article-title":"\"I'm not afraid of those ones just 'cause they've been prescribed\": perceptions of risk among illicit users of pharmaceutical opioids","volume":"23","author":"Daniulaityte","year":"2012","journal-title":"Int J Drug Pol"},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"\"Every 'never\" I ever said came true\": transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"Int J Drug Pol"},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.011_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2009.03.021","article-title":"Opioid use behaviors, mental health and pain: development of a typology of chronic pain patients","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.sapharm.2018.07.011_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.sapharm.2018.07.011_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpain.2007.02.432","article-title":"Substance use disorders in a primary care sample receiving daily opioid therapy","volume":"8","author":"Fleming","year":"2007","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib12","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.japh.2016.12.077","article-title":"Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015","volume":"57","author":"Stopka","year":"2017","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J Am Pharm Assoc."},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.011_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2017.02.021","article-title":"Pharmacist contributions to the ten essential services of public health in three National Association of Boards of Pharmacy regions","volume":"57","author":"Strand","year":"2017","journal-title":"J Am Pharm Assoc."},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sapharm.2015.06.004","article-title":"The achievement of public health services in pharmacy practice: a literature review","volume":"12","author":"Strand","year":"2016","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2018.07.011_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2146\/ajhp070399","article-title":"ASHP statement on the role of health-system pharmacists in public health","volume":"65","author":"American Society for Health-system Pharmacists","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.011_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1759-8893.2011.00074.x","article-title":"The role of community pharmacists in public health: a scoping review of the literature","volume":"3","author":"Agomo","year":"2012","journal-title":"J Pharmaceut Health Serv Res"},{"key":"10.1016\/j.sapharm.2018.07.011_bib18","first-page":"10","article-title":"Taking action to fight addiction","volume":"vol. 9","author":"Rooney","year":"2017"},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.011_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2146\/sp140002","article-title":"ASHP Statement on the pharmacist's role in substance abuse prevention, education, and assistance","volume":"71","author":"American Society for Health-system Pharmacists","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2018.07.011_bib20","doi-asserted-by":"crossref","unstructured":"American Pharmacists Association. Pharmacists' role in addressing opioid abuse, addiction, and diversion. J Am Pharm Assoc.54(1):e5\u2013e15.","DOI":"10.1331\/JAPhA.2014.13101"},{"key":"10.1016\/j.sapharm.2018.07.011_bib21","article-title":"Promising roles for pharmacists in addressing the U.S. opioid crisis","author":"Compton","year":"2018","journal-title":"Res Soc Adm Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2018.07.011_bib22","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2018.07.011_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.addbeh.2017.08.032","article-title":"Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain","volume":"76","author":"Lin","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.sapharm.2018.07.011_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.drugalcdep.2015.05.009","article-title":"Discrepancies in addressing overdose prevention through prescription monitoring programs","volume":"153","author":"Green","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.sapharm.2018.07.011_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08897077.2017.1345194","article-title":"Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking","volume":"38","author":"Mundkur","year":"2017","journal-title":"Subst Abuse"},{"key":"10.1016\/j.sapharm.2018.07.011_bib26","author":"Springer"},{"key":"10.1016\/j.sapharm.2018.07.011_bib27","doi-asserted-by":"crossref","DOI":"10.5888\/pcd13.160232","article-title":"Provision of clinical preventive services by community pharmacists","volume":"13","author":"Kelling","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.sapharm.2018.07.011_bib28","doi-asserted-by":"crossref","unstructured":"Cochran G, Gordon AJ, Field C, et al. Developing a framework of care for opioid medication misuse in community pharmacy. Res Soc Adm Pharm.12(2):293\u2013301.","DOI":"10.1016\/j.sapharm.2015.05.001"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.011_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0897190016656673","article-title":"Prescription opioid misuse among rural community pharmacy patients: pilot study for screening and implications for future practice and research","volume":"30","author":"Cochran","year":"2016","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.sapharm.2018.07.011_bib30","series-title":"Partnership-building and Information Sharing between Public Health and Pharmacies","author":"Roberts","year":"2016"},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib31","article-title":"Ensuring population health: an important role for pharmacy","volume":"80","author":"Benjamin","year":"2016","journal-title":"Am J Pharmaceut Educ"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.011_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J Am Pharm Assoc."},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.011_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091157","article-title":"The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting","volume":"9","author":"Willis","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2018.07.011_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.sapharm.2018.07.011_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5055\/jom.2014.0226","article-title":"Further validation of an opioid risk assessment tool: the Brief Risk Interview","volume":"10","author":"Jones","year":"2014","journal-title":"J Opioid Manag."},{"issue":"2","key":"10.1016\/j.sapharm.2018.07.011_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5055\/jom.2015.0266","article-title":"Validation of a new risk assessment tool: the Brief Risk Questionnaire","volume":"11","author":"Jones","year":"2015","journal-title":"J Opioid Manag."},{"key":"10.1016\/j.sapharm.2018.07.011_bib37","author":"Stenehjem"},{"key":"10.1016\/j.sapharm.2018.07.011_bib38","series-title":"NDCC 28-32-02, 43-15-10. Bismarck, ND","article-title":"Limited prescriptive authority for naloxone","author":"North Dakota Century Code","year":"2016"},{"key":"10.1016\/j.sapharm.2018.07.011_bib39","series-title":"F-m Area Opioid Group \u201cthe Right Model\u201d to Fight Addiction. The Forum Dec 15","author":"Schmidt","year":"2016"},{"issue":"4","key":"10.1016\/j.sapharm.2018.07.011_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2018.03.005","article-title":"A community pharmacy intervention for opioid medication misuse: a pilot randomized clinical trial","volume":"58","author":"Cochran","year":"2018","journal-title":"J Am Pharm Assoc."},{"issue":"8","key":"10.1016\/j.sapharm.2018.07.011_bib41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2105\/AJPH.2017.303906","article-title":"The opioid crisis and the need for compassion in pain management","volume":"107","author":"Rothstein","year":"2017","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2018.07.011_bib42","doi-asserted-by":"crossref","unstructured":"Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain\u2014development of a typology of chronic pain patients. Drug Alcohol Depend.104(1):34\u201342.","DOI":"10.1016\/j.drugalcdep.2009.03.021"},{"key":"10.1016\/j.sapharm.2018.07.011_bib43","doi-asserted-by":"crossref","unstructured":"Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain.8(7):573\u2013582.","DOI":"10.1016\/j.jpain.2007.02.432"},{"issue":"6","key":"10.1016\/j.sapharm.2018.07.011_bib44","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.japh.2017.08.011","article-title":"Linking pharmacists to the delivery of public health services","volume":"57","author":"Strand","year":"2017","journal-title":"J Am Pharm Assoc."},{"issue":"1","key":"10.1016\/j.sapharm.2018.07.011_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities from illicit fentanyl and analogues: an update","volume":"40","author":"Pichini","year":"2018","journal-title":"Ther Drug Monit"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:17:29Z","timestamp":1761556649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741118302195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1551741118302195"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.011","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}